Introduction
Coenzyme Q10 (CoQ10, ubiquinone) is a small lipophilic molecule endogenously synthesised 36 (Olson & Rudney, 1983; Tran & Clarke, 2007) in eukaryotic cells with a principal role in 37 aerobic respiration. CoQ10 is a mobile component of the electron transport chain (ETC) within 38 the mitochondrial inner membrane where it transfers electrons from NADH:ubiquinone 39 oxidoreductase (complex I) and succinate dehydrogenase (complex II) to ubiquinol-40 cytochrome c oxidoreductase (complex III) (Mas & Mori, 2010) . 41 In humans, chronic diseases such as chronic heart failure, hypertension and Parkinson's 42 disease are characterised by low plasma concentration and tissue CoQ10 content, with CoQ10 43 supplementation shown to improve clinical responses to treatment (Hofman-Bang, Rehnqvist, 44 Swedberg, Wiklund, & Åström, 1995; Jankowski, Korzeniowska, Cieślewicz, & Jabłecka, 45 2016; Mortensen et al., 2014; Yang et al., 2015) . Healthy human athletes have also been found 46 to develop CoQ10 deficiencies, believed to be due to increased metabolic demand (Cooke et 47 al., 2008; M. Kon et al., 2007; Orlando et al., 2018; Zhou, Zhang, Davie, & Marshall-Gradisnik, 48 2005). Deficiencies in skeletal muscle CoQ10 are thought to result in less efficient energy 49 transduction due to decreased ETC activity and suboptimal ATP production (Lenaz et al., 50 1999) , resulting in reduced effective skeletal muscle contractile function and earlier onset of 51 fatigue (Cooke et al., 2008; M. Kon et al., 2007; Michihiro Kon et al., 2008; Kwong et al., 52 2002; Mizuno et al., 2008) . Numerous studies support CoQ10 supplementation in human 53 athletes to improve exercise capacity, aerobic power and recovery after exercise (Alf, Schmidt, 54 & Siebrecht, 2013; Bonetti, Solito, Carmosino, Bargossi, & Fiorella, 2000; Cooke et al., 2008; 55 Leelarungrayub, Sawattikanon, Klaphajone, Pothongsunan, & Bloomer, 2010; Mizuno et al., 56 2008) . 57 Approximately 50% of the total body CoQ10 in humans is found in the mitochondrial inner 58 membrane (Greenberg & Frishman, 1990; Kumar, Kaur, Devi, & Mohan, 2009) , with organs 59 containing large numbers of mitochondria such as skeletal muscle having the largest amount 60 of CoQ10. In healthy people, plasma CoQ10 concentrations are always higher than skeletal 61 muscle with any movement of CoQ10 from plasma into skeletal muscle due to simple diffusion. 62 The rate of CoQ10 movement from the plasma into the mitochondrial inner membrane is limited 63 by the large size and lipophilic nature of this molecule (Kaikkonen, Tuomainen, Nyyssönen, & 64 Salonen, 2002; Turunen, Swiezewska, Chojnacki, Sindelar, & Dallner, 2002) , with movement 65 of exogenous CoQ10 into most tissues other than plasma previously believed to be low-to-66 absent (Svensson et al., 1999; Zhou et al., 2005) . However, oral CoQ10 supplementation has 67 been shown to elevate CoQ10 skeletal muscle mitochondrial content in rodents and humans 68 (Cooke et al., 2008; Kamzalov, Sumien, Forster, & Sohal, 2003; M. Kon et al., 2007; Linnane Committee with informed owner consent. The project was licenced under the Health Products 84 Regulatory Authority (Ireland). 85 Nineteen clinically healthy and privately-owned Thoroughbreds from one farm (11 intact 86 males [mean age 27.8±9.0 months], 8 females [mean age 27.1±11.1 months]) that were not 87 currently and had never been in an exercise training programme were included into the study. 88 Prior to and during the entire study, all horses had been/were maintained full-time in small 89 groups of 5─6 horses on 5-acre grass pastures located next to each other. The diet of the horses 90 at the time of entering into the study and during the study consisted of free-choice pasture 91 grazing and one grain meal (one standard scoop of mixed oats) given in the morning. All horses 92 had physical examinations, haematology, biochemistry and faecal evaluations performed prior 93 to inclusion into the study. Body weight (BW) was estimated for each horse at the beginning 94 of the study using a weight tape and formula (Carroll & Huntington, 1988 whole-blood within 3 hrs of collection via centrifugation (1,500 g for 5 mins) and stored at -112 20°C until batch analysis. 113 Skeletal muscle biopsies were taken from the middle gluteal muscle from standing un-114 sedated horses as previously described by Ledwith and McGowan (2004) . Once collected, all 115 samples were immediately stored on dry ice for transport to the laboratory (within 3 hrs of 116 collection) and subsequently stored at -70°C until analysis. (approximately 20 μg) were incubated in distilled H2O in a 1 ml cuvette to allow osmotic shock 167 to occur. After 2 mins incubation, the reaction components potassium phosphate pH 7.5 (50 168 mM), oxidised cytochrome c (50 μM), KCN (0.3 mM), and fatty-acid free BSA (1 mg/ml) were 169 added; a blank rate was measured for 2 mins. NADH (0.2 mM) was then added to initiate the 170 reaction with any increase in absorbance monitored for 3 mins. Following this, rotenone (10 171 μM) was added and the rate monitored for a further 2 mins. Complex I+III combined specific 172 activity was taken as the rotenone-sensitive activity determined by subtracting the rotenone-173 resistant activity from the total activity. Specific enzyme activity for complex I+III was 174 expressed as pmol/min/mg of muscle protein using the molar extinction coefficient 18,500 175 L/mol/cm for reduced cytochrome c at 550 nm. Complex I+III activity was subsequently 176 expressed as a ratio to citrate synthase activity to account for the mitochondrial enrichment of 177 the skeletal muscle homogenates. Vienna, Austria). The effects of sex and age were investigated using multivariable linear 182 regression models with interaction effects included for age and sex. Baseline age was set at 13 months (the minimum age of horses in the dataset). Horse ages were subsequently not adjusted 184 between measurement time-points as age was not identified as a significant factor in T0 plasma 185 values. Where age and sex effects were deemed non-significant and excluded from the model, 186 mean values were compared using a paired two-tailed Students t-test with 95% confidence 187 intervals. Spearman's rank correlation was performed to assess correlation between plasma 188 CoQ10 concentrations and skeletal muscle CoQ10 content. A P≤0.05 indicated significance, 189 with all results expressed as mean ± SEM unless otherwise indicated.
191

Results
192
All horses readily accepted CoQ10 supplementation with no adverse effects observed. 193 Descriptive statistics are summarised in Table 1 supplementation of an established diet. In the present study, T0 plasma CoQ10 concentrations 240 (0.13 µg/ml) were similar to a previous report evaluating 2 year-old Thoroughbreds in training 241 (0.11 µg/ml) (Horohov et al., 2012; Sinatra, Chopra, et al., 2013; Sinatra, Jankowitz, et al., 242 2013), although other publications reported slightly higher basal plasma concentrations for 243 Thoroughbreds of varying ages and fitness levels (0.19-2.1 µg/ml) (Sinatra, Chopra, et al., 244 2013; Topolovec et al., 2013) . Following prolonged oral CoQ10 supplementation the mean 245 plasma CoQ10 concentrations significantly increased as previously reported in studies using a 246 similar oral cyclodextrin-CoQ10-based delivery system (Horohov et al., 2012; Sinatra, Chopra, 247 et al., 2013; Sinatra, Jankowitz, et al., 2013) . Intestinal absorption of CoQ10 has been found to 248 be faster if CoQ10 is given with food (Ochiai et al., 2007) which is why we chose to supplement 249 the horses in the morning in conjunction with their grain meals. The dose of CoQ10 250 supplementation in the present study was well tolerated by the horses with no adverse effects 251 noted, and was chosen based on a previous study using a cyclodextrin-CoQ10-based delivery 252 system (HydroQSorb, a γ-cyclodextrin [~20%] CoQ10 complex) (Sinatra, Chopra, et al., 2013) . 253 In humans and dogs, plasma CoQ10 concentrations have been found to gradually increase as 254 the oral dosage increases (Bhagavan & Chopra, 2007) , so a higher dose may have resulted in 255 greater increases in plasma CoQ10 concentrations as observed in previous equine reports 256 (Sinatra, Jankowitz, et al., 2013) . However, the economic feasibility for owners and trainers 257 were considered, as well as the fact that in humans the efficiency of oral CoQ10 absorption 258 significantly decreases at extremely high doses (>300 mg) (Bhagavan & Chopra, 2007) . Most 259 researchers now believe that the formulation of oral CoQ10 (e.g., delivery system) is of equal 260 if not more importance to the dosage, since this highly lipophilic molecule is typically poorly 261 absorbed resulting in a low bioavailability despite the oral dose used as observed in humans, 262 rats and dogs (Bank, Kagan, & Madhavi, 2011; Zhang et al., 1995; Zhang, Turunen, & 263 Appelkvist, 1996).
264
CoQ10 is widely distributed in the body in either a reduced (i.e., ubiquinol) or oxidised (i.e., CoQ10 uptake into skeletal muscle may be similar to creatine monohydrate, in which there 315 appears to be a maximal limit and/or down-regulation of transporters reached after chronic 316 supplementation leading to a plateau and/or decrease in intramuscular content over time 317 (Guerrero-Ontiveros & Wallimann, 1998) . This warrants further investigation in the horse. 318 A limitation of this study was an inadequate number of horses available for a control group 319 based on power calculations for statistical validity. A control group would have verified 320 whether changes in dietary intake of CoQ10 other than supplementation contributed to the 321 observed increases in skeletal muscle CoQ10 content. All study horses were housed on the same 322 farm in adjacent pastures, with changes in grass CoQ10 content over the 9-week study period 323 unlikely to have occurred since plants contain an extremely small amount of CoQ10, with any 324 dietary intake for humans primarily coming from meat-based products (Kumar et al., 2009; 325 Parmar, Jaiwal, Dhankher, & Jaiwal, 2015; Pravst, Žmitek, & Žmitek, 2010) . Furthermore, 326 even including meat-based products the typical human diet does not contain enough CoQ10 to 327 significantly raise plasma CoQ10 concentrations above basal levels, with the daily CoQ10 intake 328 from food ranging between 3-5 mg/day which is too low to significantly raise blood and tissue 329 concentrations above basal levels (Wajda, Zirkel, & Schaffer, 2007) . Since the majority of 330 tissue CoQ10 content in mammals is endogenously synthesised by the mitochondria, a 331 significantly large increase in plasma CoQ10 concentration is required to incite movement into 332 tissue with human and other animal studies reporting that plasma CoQ10 concentrations and 333 skeletal muscle CoQ10 content will not significantly increase without exogenous influences 334 (Bhagavan & Chopra, 2007) . Although plasma CoQ10 concentrations in humans is typically 335 not affected by diet alone, CoQ10 supplementation has been shown to increase plasma CoQ10 336 concentrations, the extent of which depends upon the dosage, duration and type of formulation 337 (Pravst et al., 2010) . 338 It has been hypothesised that increased skeletal muscle CoQ10 should result in more efficient 339 skeletal muscle energy transduction (Lenaz et al., 1999) . For horses in active exercise training 340 this may lead to improvements in responses to exercise training, delay in the onset of fatigue 341 and enhanced recovery following intense exercise (Cooke et al., 2008; M. Kon et al., 2007; 342 Michihiro Kon et al., 2008; Kwong et al., 2002; Mizuno et al., 2008) . During exercise, 343 movement of plasma CoQ10 into skeletal muscle may increase due to increased metabolic 344 demand (M. Kon et al., 2007; Orlando et al., 2018) . This theory is supported by results from a to CoQ-responsive OXPHOS deficiency. Molecular genetics and metabolism, 450 79(4), 288-293. 451 Linnane, A. W., Kopsidas, G., Zhang, C., Yarovaya, N., Kovalenko, S., Papakostopoulos, P., . 452 . . Richardson, M. (2002) . Cellular redox activity of coenzyme Q 10: effect of CoQ 453 10 supplementation on human skeletal muscle. Free Radical Research, 36(4), [445] [446] [447] [448] [449] [450] [451] [452] [453] [454] 453.
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